This single-center observational study sought to assess the diagnosis of somatic symptom disorder (SSD) in patients with unexplained neurological symptoms occurring in the setting of long COVID. Fifty patients were included in the study. SSD diagnosis based on DSM-5 criteria was positive in 32 (64%) patients. In the remaining 18 patients, SSD was considered possible given the high score on diagnostic scales.